The results demonstrated that curcumin treatment resulted in a downregulation in the expression of TGF-β1 and p-smad3 protein in a dose-dependent manner in HCC cells (Figure 4), indicating that the TGF-β1/smad3 signaling pathway was at least partially inhibited following curcumin treatment. This evidence concerns the gene SMAD3 and hepatocellular carcinoma.